GeneSystem Co

GeneSystem Co PP&E per Employee

The PP&E per Employee of GeneSystem Co (363250.KQ) as of Oct 29, 2026 is 115.36 M KRW. In the previous year, PP&E per Employee was 86.66 M KRW — a change of 33.12% (higher).

PP&E per Employee

115.36 MKRW

YoY

33.12%

Last updated:

PP&E per Employee of GeneSystem Co is 2024 115.36 M KRW. PP&E per Employee of GeneSystem Co was 2023 86.66 M KRW. It decreases by 33.12% higher compared to the previous year.

The GeneSystem Co PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2018
2.56 M KRW
Jan 1, 2019
3.53 M KRW
Jan 1, 2020
77.07 M KRW
Jan 1, 2021
80.74 M KRW
Jan 1, 2022
80.16 M KRW
Jan 1, 2023
86.66 M KRW
Jan 1, 2024
115.36 M KRW
The GeneSystem Co PP&E per Employee history
YEARPP&E per EmployeeYoY
115.36 MKRW+33.12%
86.66 MKRW+8.10%
80.16 MKRW-0.72%
80.74 MKRW+4.77%
77.07 MKRW+2,081.00%
3.53 MKRW+38.16%
2.56 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneSystem Co Stock analysis

What does GeneSystem Co do? GeneSystem Co., Ltd generates revenue through the development, manufacturing, and sale of PCR-based molecular diagnostic products. The company offers molecular diagnosis systems, biochips, test kits, and reaction reagents, targeting healthcare providers and laboratories seeking advanced in vitro diagnostic solutions. Its core business focuses on molecular diagnosis technology, complementing immunodiagnosis technology to deliver comprehensive diagnostic tools. The firm serves medical institutions requiring precise and efficient diagnostic equipment for disease detection and monitoring. The company's product portfolio includes platform-based molecular diagnostic systems, biochips, and test kits designed for laboratory use. These products are sold directly to healthcare facilities and diagnostic laboratories, supporting applications in infectious disease testing and genetic analysis. By leveraging its expertise in molecular diagnosis, GeneSystem Co., Ltd provides essential tools for medical professionals to enhance diagnostic accuracy and patient care. GeneSystem Co., Ltd's revenue streams are derived from the sale of diagnostic systems, biochips, and consumables such as test kits and reaction reagents. The firm's target market comprises healthcare institutions and laboratories that require reliable in vitro diagnostic technology. The company's focus on molecular diagnosis technology positions it as a key supplier in the diagnostic equipment sector, meeting the growing demand for advanced diagnostic solutions in healthcare. GeneSystem Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneSystem Co stock

PP&E per Employee of GeneSystem Co is 115.36 M KRW in 2024.

PP&E per Employee of GeneSystem Co changed from 86.66 M KRW to 115.36 M KRW, representing a 33.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee GeneSystem Co since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's GeneSystem Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — GeneSystem Co

All Key Metrics — GeneSystem Co